Skip to main content

. 1985 Mar;51(3):415–417. doi: 10.1038/bjc.1985.56

A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.

P J Lachmann, R M Grant, L S Freedman, K Sikora, N M Bleehen

PMCID: PMC1976946 PMID: 3882114

415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bernstein L., Anderson J., Pike M. C. Estimation of the proportional hazard in two-treatment-group clinical trials. Biometrics. 1981 Sep;37(3):513–519. [PubMed] [Google Scholar]
Lachmann P. J., Vyakarnam A., Sikora K. The heterogenization of tumour cells with tuberculin. I. The coupling of tuberculin to cell surfaces using con-A as ligand. Immunology. 1981 Feb;42(2):329–336. [PMC free article] [PubMed] [Google Scholar]
Lennox E. S., Lowe A. D., Cohn J., Evan G. Specific antigens on methylcholanthrene-induced tumors of mice. Transplant Proc. 1981 Dec;13(4):1759–1761. [PubMed] [Google Scholar]
Lindenmann J., Klein P. A. Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J Exp Med. 1967 Jul 1;126(1):93–108. doi: 10.1084/jem.126.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sia D. Y., Lachmann P. J., Leung K. N. Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells. Immunology. 1984 Apr;51(4):755–763. [PMC free article] [PubMed] [Google Scholar]
Vyakarnam A., Lachmann P. J., Sikora K. The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice. Immunology. 1981 Feb;42(2):337–348. [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES